Clinical Trial: Treatment of Peyronie's Disease With Platelet-Rich Plasma: A Randomized, Double-blind, Placebo-controlled Clinical Trial

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07117955) titled 'Treatment of Peyronie's Disease With Platelet-Rich Plasma: A Randomized, Double-blind, Placebo-controlled Clinical Trial' on Aug. 05.

Brief Summary: The purpose of this clinical trial is to evaluate the effects of Platelet-Rich Plasma (PRP) intralesional injections in men affected by Peyronie's disease (PD) in the fibrotic phase.

Study Start Date: Sept. 20

Study Type: INTERVENTIONAL

Condition: Peyronies Disease

Intervention: OTHER: Autologous Platelet Rich Plasma

6 mL PRP intralesional injections will be administered. After the injections, participants will be instructed to perform penile stretching exercises daily until the ...